{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:08:46Z","timestamp":1786993726463,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T00:00:00Z","timestamp":1624665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2017A030313738"],"award-info":[{"award-number":["2017A030313738"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Liver Research"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.livres.2021.06.003","type":"journal-article","created":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T05:11:15Z","timestamp":1624943475000},"page":"217-223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Fructooligosaccharides enhance the therapeutic effect of xiao-zhi-fang on non-alcoholic fatty liver disease via regulating intestinal flora"],"prefix":"10.1016","volume":"5","author":[{"given":"Jiongshan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heping","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.livres.2021.06.003_bib1","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.tem.2019.08.006","article-title":"Emerging molecular targets for treatment of nonalcoholic fatty liver disease","volume":"30","author":"Chen","year":"2019","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.livres.2021.06.003_bib2","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2021.06.003_bib3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41575-019-0212-0","article-title":"Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology","volume":"17","author":"Eslam","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2021.06.003_bib4","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/hep.31150","article-title":"Epidemiological features of NAFLD from 1999 to 2018 in China","volume":"71","author":"Zhou","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2021.06.003_bib5","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/hep.30702","article-title":"Unexpected rapid increase in the burden of NAFLD in China from 2008 to 2018: a systematic review and meta-analysis","volume":"70","author":"Zhou","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2021.06.003_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2021.06.003_bib7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/03602532.2017.1293683","article-title":"Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters","volume":"49","author":"Cobbina","year":"2017","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.livres.2021.06.003_bib8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/liv.13301","article-title":"Pathology of non-alcoholic fatty liver disease","volume":"37","author":"Bedossa","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.livres.2021.06.003_bib9","doi-asserted-by":"crossref","first-page":"9330","DOI":"10.3748\/wjg.v20.i28.9330","article-title":"Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations","volume":"20","author":"Mili\u0107","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.livres.2021.06.003_bib10","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1053\/j.gastro.2018.08.024","article-title":"Risk of hepatocellular cancer in patients with non-alcoholic fatty liver disease","volume":"155","author":"Kanwal","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2021.06.003_bib11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/17460441.2018.1410135","article-title":"Non-alcoholic fatty liver disease (NAFLD) models in drug discovery","volume":"13","author":"Cole","year":"2018","journal-title":"Expet Opin Drug Discov"},{"key":"10.1016\/j.livres.2021.06.003_bib12","first-page":"1070","article-title":"Effects on various indicators of exenatide in young and middle-aged patients with type 2 diabetes and non-alcoholic fatty liver disease","volume":"21","author":"Gao","year":"2018","journal-title":"China Pharmacist"},{"key":"10.1016\/j.livres.2021.06.003_bib13","doi-asserted-by":"crossref","first-page":"5105","DOI":"10.3748\/wjg.v25.i34.5105","article-title":"Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease","volume":"25","author":"Yang","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.livres.2021.06.003_bib14","first-page":"6655335","article-title":"Hepatocardiac or cardiohepatic interaction: from traditional Chinese medicine to western medicine","volume":"2021","author":"Zhang","year":"2021","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.livres.2021.06.003_bib15","first-page":"433","article-title":"Clinical effect of the extract of TCM fructus akebiae combined with ursodeoxycholic acid on nonalcoholic fatty liver disease","volume":"32","author":"Hongguang","year":"2019","journal-title":"Pak J Pharm Scie"},{"key":"10.1016\/j.livres.2021.06.003_bib16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.53388\/ghr2019-12-006","article-title":"Network pharmacology analysis of the mechanism of action of paederia scandens in the treatment of NAFLD","volume":"1","author":"Zhu","year":"2019","journal-title":"Gastroenterol Hepatol Res"},{"key":"10.1016\/j.livres.2021.06.003_bib17","first-page":"237","article-title":"Research progress of Yinchenhao Decoction in the treatment of non-alcoholic fatty liver disease","volume":"4","author":"Ma","year":"2019","journal-title":"Drug Combination Therapy"},{"key":"10.1016\/j.livres.2021.06.003_bib18","first-page":"1","article-title":"Jian-Gan-Xiao-Zhi decoction ameliorates high-fat high-carbohydrate diet-induced non-alcoholic fatty liver disease and insulin resistance by regulating the AMPK\/JNK pathway","volume":"1","author":"Xie","year":"2021","journal-title":"Traditional Medicine Research"},{"key":"10.1016\/j.livres.2021.06.003_bib19","first-page":"78","article-title":"Clinical research of Jiangan Xiaozhi Granule in treating nonalcoholic fatty liver disease of type of qi stagnancy and blood stasis","volume":"27","author":"Wen","year":"2014","journal-title":"China Medical Herald"},{"key":"10.1016\/j.livres.2021.06.003_bib20","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3109\/07388551.2014.953443","article-title":"Biotechnological production and application of fructooligosaccharides","volume":"36","author":"Flores-Maltos","year":"2016","journal-title":"Crit Rev Biotechnol"},{"key":"10.1016\/j.livres.2021.06.003_bib21","first-page":"128","article-title":"Fructooligosaccharide: metabolism through gut microbiota and prebiotic effect","volume":"2","author":"Oku","year":"2017","journal-title":"Food Nutr J"},{"key":"10.1016\/j.livres.2021.06.003_bib22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/biof.147","article-title":"Fructooligosaccharides suppress high-fat diet-induced fat accumulation in C57BL\/6J mice","volume":"43","author":"Nakamura","year":"2017","journal-title":"Biofactors"},{"key":"10.1016\/j.livres.2021.06.003_bib23","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1093\/jas\/sky110","article-title":"Supplementation of fructooligosaccharides to suckling piglets affects intestinal microbiota colonization and immune development","volume":"96","author":"Schokker","year":"2018","journal-title":"J\u00a0Anim Sci"},{"key":"10.1016\/j.livres.2021.06.003_bib24","first-page":"1535","article-title":"Modulation of fructo-oligosaccharide during silybin-meditated improvement of nonalcoholic fatty liver","volume":"11","author":"Li","year":"2017","journal-title":"Chin Pharmacol Bull"},{"key":"10.1016\/j.livres.2021.06.003_bib25","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.2174\/1381612825666190117102111","article-title":"Diagnosis of non-alcoholic fatty liver disease (NAFLD): current concepts","volume":"24","author":"Papatheodoridi","year":"2018","journal-title":"Curr Pharmaceut Des"},{"key":"10.1016\/j.livres.2021.06.003_bib26","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3389\/fphar.2020.00877","article-title":"Hydrogen: an endogenous regulator of liver homeostasis","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.livres.2021.06.003_bib27","doi-asserted-by":"crossref","first-page":"8786424","DOI":"10.1155\/2020\/8786424","article-title":"Si-Wu-Tang alleviates nonalcoholic fatty liver disease via blocking TLR4-JNK and caspase-8-GSDMD signaling pathways","author":"Zhang","year":"2020","journal-title":"Evid Based Complement Alternat Med. 2020"},{"key":"10.1016\/j.livres.2021.06.003_bib28","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jhep.2016.03.006","article-title":"Tumor necrosis factor receptor-associated factor 5 (Traf5) acts as an essential negative regulator of hepatic steatosis","volume":"65","author":"Gao","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2021.06.003_bib29","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.3389\/fphys.2018.01813","article-title":"Intestinal microbiota modulation in obesity-related non-alcoholic fatty liver disease","volume":"9","author":"Porras","year":"2018","journal-title":"Front Physiol"},{"key":"10.1016\/j.livres.2021.06.003_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.cld.2017.10.001","article-title":"Nonalcoholic fatty liver disease: an expanding health care epidemic","volume":"22","author":"Bernstein","year":"2018","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.livres.2021.06.003_bib31","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.bpg.2014.07.008","article-title":"Non-alcoholic fatty liver disease, obesity and the metabolic syndrome","volume":"28","author":"Dietrich","year":"2014","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.livres.2021.06.003_bib32","doi-asserted-by":"crossref","first-page":"106040","DOI":"10.1016\/j.intimp.2019.106040","article-title":"A\u00a0network pharmacology approach to investigate the anti-inflammatory mechanism of effective ingredients from Salvia miltiorrhiza","volume":"81","author":"Cui","year":"2020","journal-title":"Int Immunopharm"},{"key":"10.1016\/j.livres.2021.06.003_bib33","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1590\/s1806-92902017000400009","article-title":"Carcass traits and short-chain fatty acid profile in cecal digesta of piglets fed alfalfa hay and fructooligosaccharides","volume":"46","author":"Rodrigues","year":"2017","journal-title":"Rev Bras Zootec"},{"key":"10.1016\/j.livres.2021.06.003_bib34","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/09637486.2018.1511688","article-title":"Fructooligosaccharide enhanced absorption and anti-dyslipidemia capacity of tea flavonoids in high sucrose-fed mice","volume":"70","author":"Li","year":"2019","journal-title":"Int J Food Sci Nutr"},{"key":"10.1016\/j.livres.2021.06.003_bib35","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.3382\/ps\/pev049","article-title":"Potential of fructooligosaccharide prebiotics in alternative and nonconventional poultry production systems","volume":"94","author":"Ricke","year":"2015","journal-title":"Poult Sci"},{"key":"10.1016\/j.livres.2021.06.003_bib36","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.foodres.2017.07.070","article-title":"Effect of symbiotic interaction between a fructooligosaccharide and probiotic on the kinetic fermentation and chemical profile of maize blended rice beverages","volume":"100","author":"Freire","year":"2017","journal-title":"Food Res Int"},{"key":"10.1016\/j.livres.2021.06.003_bib37","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1039\/C6FO01783E","article-title":"Impact and consequences of polyphenols and fructooligosaccharide interplay on gut microbiota in rats","volume":"8","author":"Zheng","year":"2017","journal-title":"Food Funct"},{"key":"10.1016\/j.livres.2021.06.003_bib38","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrgastro.2018.26","article-title":"Intestinal tract: a breach in the intestinal barrier during hyperglycaemia","volume":"15","author":"Ray","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2021.06.003_bib39","doi-asserted-by":"crossref","first-page":"121","DOI":"10.31083\/j.rcm.2019.03.518","article-title":"Diet-induced chronic syndrome, metabolically transformed trimethylamine-N-oxide, and the cardiovascular functions","volume":"20","author":"Hardin","year":"2019","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.livres.2021.06.003_bib40","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/535047a","article-title":"Intestinal microbiota in health and disease","volume":"535","author":"K\u00e5hrstr\u00f6m","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.livres.2021.06.003_bib41","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1056\/NEJMra1600266","article-title":"The human intestinal microbiome in health and disease","volume":"375","author":"Lynch","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.livres.2021.06.003_bib42","unstructured":"Ma MJ, Wu J. Association between intestinal flora imbalance and nonalcoholic fatty liver disease [in Chinese]. Zhonghua Gan Zang Bing Za Zhi. 25:789-793. doi: 10.3760\/cma.j.issn.1007-3418.2017.10.017."},{"key":"10.1016\/j.livres.2021.06.003_bib43","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.bpg.2017.09.008","article-title":"NAFLD, helicobacter species and the intestinal microbiome","volume":"31","author":"Casta\u00f1o-Rodr\u00edguez","year":"2017","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.livres.2021.06.003_bib44","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.micpath.2016.02.005","article-title":"Akkermansia muciniphila and its role in regulating host functions","volume":"106","author":"Derrien","year":"2017","journal-title":"Microb Pathog"},{"key":"10.1016\/j.livres.2021.06.003_bib45","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3920\/BM2016.0009","article-title":"Akkermansia muciniphila: a novel functional microbe with probiotic properties","volume":"7","author":"G\u00f3mez-Gallego","year":"2016","journal-title":"Benef Microbes"},{"key":"10.1016\/j.livres.2021.06.003_bib46","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12944-018-0801-x","article-title":"The influence of the intestinal microflora to the efficacy of Rosuvastatin","volume":"17","author":"Wang","year":"2018","journal-title":"Lipids Health Dis"}],"container-title":["Liver Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S254256842100043X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S254256842100043X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T14:45:13Z","timestamp":1762872313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S254256842100043X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S254256842100043X"],"URL":"https:\/\/doi.org\/10.1016\/j.livres.2021.06.003","relation":{},"ISSN":["2542-5684"],"issn-type":[{"value":"2542-5684","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fructooligosaccharides enhance the therapeutic effect of xiao-zhi-fang on non-alcoholic fatty liver disease via regulating intestinal flora","name":"articletitle","label":"Article Title"},{"value":"Liver Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.livres.2021.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Third Affiliated Hospital of Sun Yat-sen University. Publishing services by Elsevier B. V. on behalf of KeAi Communications Co., Ltd.","name":"copyright","label":"Copyright"}]}}